Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.47
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Join SI Premium – FREE
Dr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.47, versus $0.56 reported last year. Revenue for the quarter came in at $580 million, versus $557 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Brunswick (BC) Reports In-Line Q1 EPS, provides guidance
- SAGE Therapeutics (SAGE) Misses Q1 EPS by 15c, provides guidance
- Darling Ingredients (DAR) Misses Q1 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
